MANNING PAUL B purchased 35.9% of their position (750K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market purchase worth $2.06M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/3/2025ACC: 0001415889-25-015480
Director10% Owner
Since Sep 2020
+750K
Net shares
Net buyer
$2.06M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
750K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+750K
Price / share
$2.75
Trade value
$2.06M
% of position
35.9%
5/30/2025
2.09M→2.84M
Total
Net shares
+750K
Net value
$2.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/30/2025 | P · Purchase | +750K | $2.75 | $2.06M | 35.9% | 2.09M | 2.84M |
| Total | +750K | $2.06M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned22K
Common Stock
IndirectShares owned4.01M
Common Stock
IndirectShares owned4M
Common Stock
IndirectShares owned14.72M
Total
22.76M indirect22.76M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22K | Indirect |
| Common Stock | 4.01M | Indirect |
| Common Stock | 4M | Indirect |
| Common Stock | 14.72M | Indirect |
| Total | 22.76M | 22.76M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported